Sign-up for our newsletter
Protocols & Methods
Reagents & Resources
IMPC / KOMP Data
Prognostic Imaging and Blood Markers of Wound Healing Among Patients with Diabetic Foot Ulcers
The objective of this proposal is to establish and translate novel noninvasive imaging methods and blood markers prognostic of incomplete wound healing in the setting of diabetic foot ulcers (DFU). Over 30 million people live with diabetes in the United States. Diabetic foot ulcers (DFU) account for 25-50% of all diabetes-related hospital costs in the US totaling approximately $40 billion per year and are often the first recognized sign of impending limb loss. The lifetime risk for DFU is up to 25% and its treatment is resource-intensive requiring antibiotics, frequent wound care, and surgical procedures, yet 1-year healing rates are only 75%. Once an ulcer forms, the risk of limb loss is high with up to 20% of patients undergoing lower-extremity amputation. Strong basic and clinical evidence demonstrates both initiation of ulcers and poor wound healing arise from reduced tissue perfusion and ischemia. Diminished oxidative capacity in circulating immune cells have been implicated in disease states associated with poor wound healing. Currently there are no effective clinical tools for predicting DFU. With the long-term goal of improving the clinical outcomes, we will examine the influence of microvascular impairment and reduced immune cell energetics on wound healing in patients with DFU. In human subjects, we have demonstrated both robust in vivo magnetic resonance imaging approaches for quantifying resting tissue perfusion and microvascular reserve. We have also demonstrated the ability to measure reductions in monocyte reserve respiratory capacity in obesity compared with normal weight human subjects. With this technical foundation established, the proposed study will extend these methods for improved characterization of incomplete wound repair in diabetic foot ulcers. In this pilot study, we will pursue two related specific aims. In Aim 1, we will establish MRI measurements to characterize microcirculatory abnormalities in patients with diabetic foot ulcers. In Aim 2, we will test for reduced monocyte reserve respiratory capacity in patients with diabetic foot ulcers. If successful, this work will establish proof-of-principle data for the use of imaging and blood markers to assess diminished microcirculatory and immune cellular energetic capacity in the setting of DFU. The results from this pilot study are expected to provide important data on measurement sensitivity to support the design of follow-up longitudinal work to examine and disentangle the combined and/or independent influences of microcirculatory and energetic impairment in DFU patients that exhibit incomplete wound repair; this will form the basis of an R-level NIH proposal. Ultimately, we expect this will provide novel information for more effective treatment strategies of DFU and allow for improved patient selection for trials evaluating novel DFU wound healing therapies.
Drag a column header and drop it here to group by that column
Prognostic Imaging and Blood Markers of Wound Healing Among Patients with Diabetic Foot Ulcers (Reiter, David)
View Progress Report Document
No uploaded documents found.
No publications found.
No uploaded documents found.
No protocols found.
The DiaComp Steering Committee is the governing body of the consortium. The principle function of this committee is to guide the scientific direction of the consortium. This is accomplished by creating various subcommittees necessary to advance the scientific goals and providing guidance to the broader complications research community. Policies for the consortium are developed through consultation with the
External Evaluation Committee
The DiaComp Wound Healing Committee has the principal function of furthering the mission of the consortium with regard to diabetic wound healing.
Curation Flag Information
New comment to be added:
No records to display.
Welcome to the DiaComp Login / Account Request Page.
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
There was a problem with the page:
Safari Browser Detected...
We strive to make the DiaComp site compatable with as many browsers as possible, but some of our third party tools don't work with the Safari browser.
In order to explore this site we highly recommend using the most recent versions of the following browsers:
© 2018 DiaComp.org
All rights reserved
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!